By Dave Muoio
In a speech and new report, the U.S. president pointed to data indicating major increases in employee vaccination rates and relatively few resignations following vaccination requirements. About 40% of all U.S. hospitals have publicly announced a vaccination requirement for their workforce.
read more
By Eric Sagonowsky
As Supernus' top drug Trokendi inches toward the patent cliff, the central nervous system-focused drugmaker has struck an M&A deal to quickly expand its portfolio of marketed medicines.
read more
By Annalee Armstrong
Almost a year to the day after Gossamer Bio’s lead program failed twice in phase 2, the California biotech is unveiling two preclinical assets ready to enter the clinic in an effort to turn things around.
read more
By Conor Hale
Medtronic has secured European approval for its Hugo surgical robot, clearing the way for the system to make its continental debut in multiple countries.
read more
By Angus Liu
Delivering postsurgical analgesic Exparel to blockbusterland is no longer enough for Pacira BioSciences’ appetite. The company is now reaching for its mergers and acquisitions war chest to expand its nonopioid pain management offerings.
read more
By Andrea Park
Many hospitals and health systems talk a big game about integrating artificial intelligence into nearly every aspect of clinical care, but Mount Sinai, for one, is actually putting its money where its mouth is.
read more
By Anastassia Gliadkovskaya
Hospitals charge patients widely ranging prices for the same basic services, a recent New York Times investigation found. As federal regulators push for more price transparency, experts argue that the published data are not necessarily an accurate representation of the price a patient might pay and, in the end, the CMS rule does not help patients shop for services.
read more
By Eric Sagonowsky
For a small company seeking to market a rival to a dominant brand, a patent lawsuit from a global pharma giant would seem to be a cause for concern. But Revance has a good chance of beating back AbbVie's recent patent case, one team of analysts figures.
read more
By Dave Muoio
Nearly 21,000 of the nonprofit's nurses and workers based in Southern California could walk off the job, according to their union. The dispute centers around contractual pay increases they say are insufficient and will hamper recruitment during the next few years.
read more
By Conor Hale
The company also delivered recent findings that showed the Percepta genomic test’s ability to more accurately separate groups of patients based on their risk of developing tumors from suspicious lung nodules.
read more
By Paige Minemyer
PopHealthCare, a subsidiary of GuideWell, is launching a new national medical group that aims to offer a slew of value-based care services to payers nationwide.
read more
.png)
